Treatment Strategies in Metastatic Renal Cancer: Dose Titration in Clear Cell Renal Cell Carcinoma

Affiliations

¹ Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. Electronic address: j.e.brown@sheffield.ac.uk.
² Edinburgh Cancer Centre, University of Edinburgh, Edinburgh, UK.

Editorial

Janet E Brown et al. Eur Urol. 2022 Sep.

. 2022 Sep;82(3):293-294.

doi: 10.1016/j.eururo.2022.04.018. Epub 2022 May 14.

¹ Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. Electronic address: j.e.brown@sheffield.ac.uk.
² Edinburgh Cancer Centre, University of Edinburgh, Edinburgh, UK.

No abstract available

Comment on

Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial.
Pal SK, Puente J, Heng DYC, Glen H, Koralewski P, Stroyakovskiy D, Alekseev B, Parnis F, Castellano D, Ciuleanu T, Lee JL, Sunela K, O'Hara K, Binder TA, Peng L, Smith AD, Rha SY. Pal SK, et al. Eur Urol. 2022 Sep;82(3):283-292. doi: 10.1016/j.eururo.2021.12.024. Epub 2022 Feb 21. Eur Urol. 2022. PMID: 35210132 Clinical Trial.